Skip to content

Study · Randomized controlled trial · n = 113 · 2020

1 result

Heart and brain: Cortical representation of cardiac signals is disturbed in borderline personality disorder, but unaffected by oxytocin administration.

Schmitz M, Müller LE, Schulz A, Kleindienst N, Herpertz SC, Bertsch K

Journal of affective disorders30 Nov 2019Cited by 28 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In women with borderline personality disorder and healthy controls, oxytocin had no significant effect on heartbeat-evoked potential amplitude compared with placebo.

    In plain wordsIn women with borderline personality disorder and healthy women, oxytocin did not change the brain's response to the heartbeat, compared with placebo.

    Peptide
    Oxytocin
    Outcome
    No significant changeHeartbeat-evoked potential amplitude
    Study

    n = 113

    Comparator
    Placebo
    Outcome group
    Heart function · Nervous system and cognition
    Studied dose
    24 IUAs given in this study (human).

    Source sentences

    Summary
    However, oxytocin had no significant effect on HEP amplitude.
    2 context sentences
    Summary · context
    Fifty-three medication-free women with a DSM-IV diagnosis of BPD and sixty healthy female controls (HCs) participated in the study.
    Summary · context
    In a randomized, double-blind placebo-controlled trial, participants self-administered either 24 I.U. of oxytocin or placebo and took part in a 5-minute resting-state electrocardiogram (ECG) with parallel electroencephalogram (EEG) measurement.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:48 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.